Nuvectis Pharma, Inc. (NVCT)
21.08
+0.06
(+0.29%)
USD |
NASDAQ |
Nov 10, 16:00
21.19
+0.11
(+0.52%)
After-Hours: 20:00
Nuvectis Pharma 1 Year Total Returns (Daily) : 247.3% for Nov. 10, 2026
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| November 10, 2026 | 247.3% |
| November 09, 2026 | 242.3% |
| November 06, 2026 | 268.8% |
| November 05, 2026 | 214.3% |
| November 04, 2026 | 214.1% |
| November 03, 2026 | 204.1% |
| November 02, 2026 | 185.8% |
| October 30, 2026 | 178.3% |
| October 29, 2026 | 174.3% |
| October 28, 2026 | 185.5% |
| October 27, 2026 | 181.5% |
| October 26, 2026 | 198.2% |
| October 23, 2026 | 233.6% |
| October 22, 2026 | 252.9% |
| October 21, 2026 | 243.9% |
| October 20, 2026 | 232.1% |
| October 19, 2026 | 207.0% |
| October 16, 2026 | 205.4% |
| October 15, 2026 | 210.8% |
| October 14, 2026 | 198.5% |
| October 13, 2026 | 193.2% |
| October 12, 2026 | 230.4% |
| October 09, 2026 | 251.4% |
| October 08, 2026 | 223.1% |
| October 07, 2026 | 232.1% |
| Date | Value |
|---|---|
| October 06, 2026 | 231.1% |
| October 05, 2026 | 256.2% |
| October 02, 2026 | 261.1% |
| October 01, 2026 | 241.9% |
| September 30, 2026 | 250.8% |
| September 29, 2026 | 246.8% |
| September 28, 2026 | 242.3% |
| September 25, 2026 | 239.8% |
| September 24, 2026 | 263.5% |
| September 23, 2026 | 251.2% |
| September 22, 2026 | 257.7% |
| September 21, 2026 | 250.6% |
| September 18, 2026 | 243.8% |
| September 17, 2026 | 245.4% |
| September 16, 2026 | 252.2% |
| September 15, 2026 | 254.1% |
| September 14, 2026 | 279.1% |
| September 11, 2026 | 268.5% |
| September 10, 2026 | 258.1% |
| September 09, 2026 | 259.3% |
| September 08, 2026 | 274.8% |
| September 04, 2026 | 275.6% |
| September 03, 2026 | 283.8% |
| September 02, 2026 | 274.9% |
| September 01, 2026 | 251.5% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Opus Genetics, Inc. | 114.7% |
| Faeth Therapeutics, Inc. | 34.44% |
| ACADIA Pharmaceuticals, Inc. | -17.66% |
| Alnylam Pharmaceuticals, Inc. | -65.67% |
| Anika Therapeutics, Inc. | 33.76% |